Oniris® is a thermoplastic, bi-block oral appliance that gently advances the mandible to maintain airway patency during sleep. The device is custom-mouldable chairside and features a millimetre-accurate titration mechanism for precise and comfortable mandibular positioning. It offers a practical solution for patients who are looking for a short-term CPAP alternative, are CPAP-intolerant or as a first-line intervention while awaiting diagnosis or treatment through sleep clinics.

Supported by multiple clinical studies, including the IRIS study (a multi-centre randomised controlled trial), Oniris® has demonstrated comparable effectiveness to custom-made devices in reducing apnoea-hypopnoea index (AHI), while also achieving high levels of patient satisfaction, comfort, and compliance.

With growing awareness of the connection between oral health and systemic conditions—such as sleep-related breathing disorders—Oniris® empowers dental professionals to take a proactive role in screening and managing these issues. The device fits easily into routine clinical workflows, with no laboratory work required and minimal chair time for fitting.

Dental professionals are invited to visit Oraldent at Stand D70 during the BDA Conference and Dental Show 2025 in Birmingham to experience Oniris® first-hand and discover how this innovative oral appliance can help expand treatment options, enhance patient care, and support interdisciplinary collaboration in dental sleep medicine.

For more information, contact Oraldent at 01480 862080, email info@oraldent.co.uk, or visit www.oraldent.co.uk.